In contrast to CML patients with no BCR::ABL1 KD mutation at diagnosis, two Ph+ ALL patients harbored BCR::ABL1 KD mutations at the time of diagnosis. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.